Ospedale Isola Tiberina-Gemelli Isola — Rome

Public research footprint of Ospedale Isola Tiberina-Gemelli Isola, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung (NSCLC) · Alzheimers Disease · Neovascular Age-related Macular Degeneration

Recently updated registry entries

NCT07177352 — Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's… (Recruiting)
NCT07144280 — A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel… (Recruiting)
NCT06847542 — A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Ospedale Isola Tiberina-Gemelli Isola?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.